Secondary Logo

January 2019 - Volume 42 - Issue 1

  • David E. Wazer, MD
  • 0277-3732
  • 1537-453X
  • 12 issues per year
  • Oncology 97/217
  • 3.424

Current Issue Highlights

Soft Tissue

Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity

Chowdhary, Mudit; Sen, Neilayan; Jeans, Elizabeth B.; More

American Journal of Clinical Oncology. 42(1):1-5, January 2019.


Utilization of an Alternative Docetaxel-based Intraperitoneal Chemotherapy Regimen in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma: A Continued Need for Ovarian Cancer Patients

Becker, David A.; Leath, Charles A. III; Walters-Haygood, Christen L.; More

American Journal of Clinical Oncology. 42(1):12-16, January 2019.

Central Nervous System


Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation

Zhong, Jim; Switchenko, Jeffrey; Jegadeesh, Naresh K.; More

American Journal of Clinical Oncology. 42(1):36-41, January 2019.





Differential Outcomes Among Immunosuppressed Patients With Merkel Cell Carcinoma: Impact of Immunosuppression Type on Cancer-specific and Overall Survival

Cook, Maclean; Baker, Kelsey; Redman, Mary; More

American Journal of Clinical Oncology. 42(1):82-88, January 2019.

Head and Neck

Challenging the Requirement to Treat the Contralateral Neck in Cases With >4 mm Tumor Thickness in Patients Receiving Postoperative Radiation Therapy for Squamous Cell Carcinoma of the Oral Tongue or Floor of Mouth

O’steen, Lillie; Amdur, Robert J.; Morris, Christopher G.; More

American Journal of Clinical Oncology. 42(1):89-91, January 2019.